- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 17/10 - Anti-acne agents
Patent holdings for IPC class A61P 17/10
Total number of patents in this class: 1675
10-year publication summary
|
47
|
90
|
125
|
135
|
130
|
152
|
107
|
127
|
108
|
28
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Galderma Research & Development | 372 |
59 |
| Pierre Fabre Dermo-Cosmetique | 363 |
29 |
| Beiersdorf AG | 3073 |
26 |
| DSM IP Assets B.V. | 5449 |
23 |
| Kenvue Brands LLC | 1003 |
21 |
| S-Biomedic NV | 40 |
20 |
| L' Oréal | 5705 |
20 |
| Bausch Health Ireland Limited | 813 |
19 |
| Conopco, Inc. | 5003 |
18 |
| The Regents of the University of California | 20473 |
18 |
| Sol-gel Technologies Ltd. | 116 |
18 |
| Galderma S.A. | 124 |
16 |
| Unilever Global IP Limited | 2135 |
16 |
| Allergan, Inc. | 2225 |
15 |
| Mayne Pharma LLC | 57 |
14 |
| Journey Medical Corporation | 95 |
12 |
| Eligo Bioscience | 91 |
12 |
| Colgate-Palmolive Company | 5740 |
11 |
| Unilever IP Holdings B.V. | 2745 |
11 |
| Novartis AG | 10376 |
10 |
| Other owners | 1287 |